Pharma IT ManCo ApS Financials, key figures and credit report
Gross profit -38.6 kDKK FY 2025 -11.3% vs 2024
EBIT -38.6 kDKK FY 2025 +99.7% vs 2024
Net debt 6 359.4 kDKK FY 2025 -60.9% vs 2024
Quick ratio 0.0 FY 2025 -3.5 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| External services | -12.67 | -19.90 | -34.67 | -38.61 |
| Gross profit | -12.67 | -19.90 | -34.67 | -38.61 |
| Other operating expenses | -15 229.97 | |||
| EBIT | -12.67 | -19.90 | -15 264.64 | -38.61 |
| Other financial income | 1 569.99 | 509.88 | ||
| Other financial expenses | -4.57 | -29.49 | ||
| Reduction non-current investment assets | -9 664.72 | |||
| Net income from associates (fin.) | 46 908.91 | 41 535.80 | ||
| Pre-tax profit | -12.67 | 46 889.00 | 27 836.58 | -9 222.94 |
| Income taxes | - 330.18 | - 103.31 | ||
| Net earnings | -12.67 | 46 889.00 | 27 506.40 | -9 326.25 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Participating interests | 61 230.63 | |||
| Investments total | 61 230.63 | |||
| Non-current loans receivable | -30 615.31 | 43 930.52 | 34 265.81 | |
| Long term receivables total | -30 615.31 | 43 930.52 | 34 265.81 | |
| Inventories total | ||||
| Current other receivables | 83 801.15 | 58 553.40 | ||
| Short term receivables total | 83 801.15 | 58 553.40 | ||
| Cash and bank deposits | 40.00 | 38.43 | 7.69 | 3.96 |
| Cash and cash equivalents | 40.00 | 38.43 | 7.69 | 3.96 |
| Balance sheet total (assets) | 30 655.31 | 83 839.58 | 102 491.62 | 34 269.77 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 |
| Share premium account | 30 605.31 | |||
| Shares repurchased | 48 812.92 | |||
| Other reserves | -48 812.92 | |||
| Retained earnings | 30 592.64 | 58 291.24 | 36 984.72 | |
| Profit of the financial year | -12.67 | 46 889.00 | 27 506.40 | -9 326.25 |
| Shareholders equity total | 30 642.64 | 77 531.65 | 85 847.64 | 27 708.47 |
| Non-current liabilities total | ||||
| Current trade creditors | 10.00 | 10.00 | 20.00 | 20.00 |
| Current owed to participating | 2.67 | 6 279.60 | 12 506.75 | 2 615.36 |
| Current owed to group member | 3 747.77 | 3 748.05 | ||
| Short-term deferred tax liabilities | 330.18 | 103.31 | ||
| Other non-interest bearing current liabilities | 18.34 | 39.27 | 74.58 | |
| Current liabilities total | 12.67 | 6 307.93 | 16 643.97 | 6 561.29 |
| Balance sheet total (liabilities) | 30 655.31 | 83 839.58 | 102 491.62 | 34 269.77 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated